Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 5,338,732

« Back to Dashboard

Summary for Patent: 5,338,732

Title: Megestrol acetate formulation
Abstract:The present invention relates to a novel oral pharmaceutical composition of micronized megestrol acetate at a concentration of 15 to 150 mg/mL comprising polysorbate at a concentration of 0.005% to 0.015% weight/volume and polyethylene glycol at a concentration of 5-30% weight/volume which composition forms a stable flocculated suspension in water. The invention further comprises the micronized megestrol acetate formulation described above with added preservatives, buffers, sweeteners and flavoring agents.
Inventor(s): Atzinger; Anne E. (Lebanon, IN), Bequette; Robert J. (Evansville, IN), Davis; Robert E. (Evansville, IN)
Assignee: Bristol-Myers Squibb Company (New York, NY)
Application Number:07/882,218
Patent Claim Types:
see list of patent claims

No matches for this query

International Patent Family for Patent: 5,338,732

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2071141► Subscribe
China1067580► Subscribe
China1038904► Subscribe
Czech Republic9201853► Subscribe
Czech Republic289620► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.